Meeting
2022 ASCO Quality Care Symposium
Reasons for declining participation in breast cancer trials among minorities at a safety-net health system.
Authors
Fabian E. Robles
UT Southwestern Medical Center, Dallas, TX
Fabian E. Robles, Nasir Qureshi, Nisha Unni, Samira K. Syed, Hsiao Ching Li, Navid Sadeghi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Access to Clinical Trials
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 95)
DOI
10.1200/JCO.2022.40.28_suppl.095
Abstract #
95
Poster Bd #
C28
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Increase in postmenopausal women with distant stage breast cancer in the United States over the last 18 years: Who is the most at risk?
First Author: Arya Aliabadi
Poster
2020 ASCO Quality Care Symposium
Long-term impact of patient navigation (PN) for breast cancer (BCA) screening in an urban academic medical center.
First Author: Lisa Phuong
Poster
2024 ASCO Annual Meeting
Patient-reported provider communication skills and adherence to recommended treatment in breast cancer.
First Author: Fumiko Chino
Poster
2023 ASCO Quality Care Symposium
A qualitative study on the role of financial toxicity on adoption of healthy lifestyle behavior after breast cancer among Black and Latina women.
First Author: Celeste K Nsubayi